Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Efficacy of Carminal on the Gastric Mucosa in Patients With Helicobacter Pylori Positive Gastritis

NCT07179237 is registered in ClinicalTrials.gov with Catalysis SL as lead sponsor.

NCT NCT07179237
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07179237 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Efficacy of Carminal on the Gastric Mucosa in Patients With Helicobacter Pylori Positive Gastritis
Lead sponsor
Catalysis SL
Phase
Phase 2
Overall status
Recruiting
Start date
August 4, 2025
Completion date
October 5, 2026
Enrollment
80 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gastric mucosal lesion, gastritis associated with helicobacter pylori, h pylori eradication, h pylori gastritis, h pylori infection